Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies.

Molecular Cancer Therapeutics
Yu ZhouJames D Marks

Abstract

Aberrant expression and activation of EGF receptor (EGFR) has been implicated in the development and progression of many human cancers. As such, targeted therapeutic inhibition of EGFR, for example by antibodies, is a promising anticancer strategy. The overall efficacy of antibody therapies results from the complex interplay between affinity, valence, tumor penetration and retention, and signaling inhibition. To gain better insight into this relationship, we studied a panel of EGFR single-chain Fv (scFv) antibodies that recognize an identical epitope on EGFR but bind with intrinsic monovalent affinities varying by 280-fold. The scFv were converted to Fab and IgG formats, and investigated for their ability to bind EGFR, compete with EGF binding, and inhibit EGF-mediated downstream signaling and proliferation. We observed that the apparent EGFR-binding affinity for bivalent IgG plateaus at intermediate values of intrinsic affinity of the cognate Fab, leading to a biphasic curve describing the ratio of IgG to Fab affinity. Mathematical modeling of antibody-receptor binding indicated that the biphasic effect results from nonequilibrium assay limitations. This was confirmed by further observation that the potency of EGF competition ...Continue Reading

References

May 1, 1986·The Journal of Pathology·B OzanneB Gusterson
Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
May 1, 1995·Immunotechnology : an International Journal of Immunological Engineering·R SchierL M Weiner
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·A NowakowskiJ D Marks
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten O NielsenCharles M Perou
Sep 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wim K BleekerPaul W H I Parren
Jan 10, 2006·Cancer Biotherapy & Radiopharmaceuticals·Eva HorakJames D Marks
Aug 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yong TangLouis M Weiner
Apr 15, 2008·Cancer Immunology, Immunotherapy : CII·Michael M SchmidtK Dane Wittrup
Mar 24, 2009·Lancet·Louis M WeinerSoldano Ferrone
Dec 2, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tanja Schneider-MerckMichael Dechant

❮ Previous
Next ❯

Citations

May 10, 2016·Analytical Biochemistry·Shima Moradi-KalbolandiMohammad Ali Shokrgozar
Nov 12, 2016·Trends in Pharmacological Sciences·James R KintzingJennifer R Cochran
May 23, 2017·Nature Communications·Thi-Huong NguyenAndreas Greinacher
Oct 17, 2019·Frontiers in Oncology·Jesús García-FoncillasSebastian Stintzing
Sep 17, 2020·International Journal of Molecular Sciences·Zora NovakovaCyril Barinka
Aug 11, 2020·Journal of Biological Research·Ioannis PaspaltsisNikolaos Grigoriadis
Oct 9, 2020·Scientific Reports·Yu Tang, Yanguang Cao
Nov 5, 2019·Journal of Molecular Biology·Vincenzo AlterioGiuseppina De Simone
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nichole E M KaufmanMaria da Graça H Vicente
Aug 28, 2021·Biomedicines·Philipp Wolf
May 16, 2019·Analytical Chemistry·Si Chen, P I Imoukhuede

❮ Previous
Next ❯

Related Concepts

Related Feeds

Related Papers

Nature Reviews. Cancer
Andrew I Minchinton, Ian F Tannock
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Greg M ThurberK Dane Wittrup
© 2021 Meta ULC. All rights reserved